Bulletin
Investor Alert

New York Markets Close in:

Atea Pharmaceuticals Inc.

NAS: AVIR

GO
/marketstate/country/us

Countdown to close

/zigman2/quotes/222210381/composite

$

5.47

Change

-0.03 -0.52%

Volume

Volume 423,381

Sep 27, 2022, 3:51 p.m.

Real time quotes

/zigman2/quotes/222210381/composite

Previous close

$ 5.50

$ 5.47

Change

-0.03 -0.52%

Day low

Day high

$5.41

$5.76

Open
Open: 5.56

52 week low

52 week high

$5.31

$46.91

Open

Market cap

$457.92M

Average volume

448,268

P/E ratio

45.01

Rev. per Employee

$3.81M

EPS

0.12

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/avir

MarketWatch News on AVIR

  1. Biotech Stocks Are Still Falling. The Near-Term Outlook Is Grim.

    10:21 a.m. May 2, 2022

    - Barron's Online

  2. 8 Biotechs So Cheap Their Technology Is Effectively Free

    6:34 p.m. Feb. 16, 2022

    - Barron's Online

  3. Here Are 8 Biotech Stocks That Trade for Less Than Their Cash

    9:28 a.m. Dec. 28, 2021

    - Barron's Online

  4. Pfizer's Covid Antiviral Shows Stunning Efficacy

    11:46 p.m. Nov. 5, 2021

    - Barron's Online

  5. Atea Pharmaceuticals stock price target cut to $16 from $61 at J.P. Morgan

    7:56 a.m. Oct. 20, 2021

    - Tomi Kilgore

  6. Atea Pharmaceuticals downgraded to neutral from overweight at J.P. Morgan

    7:55 a.m. Oct. 20, 2021

    - Tomi Kilgore

  7. Why Facebook May Be Changing Its Name

    11:42 a.m. Oct. 20, 2021

    - Barron's Online

  8. Stocks Closed Up Today. Profits Are a Beautiful Thing.

    5:30 p.m. Oct. 19, 2021

    - Barron's Online

  9. Don't Count Out Covid-19 Monoclonal Antibody Treatments

    11:33 a.m. Oct. 15, 2021

    - Barron's Online

  10. FDA Will Consider Regeneron's Covid-19 Antibody for Full Approval

    10:39 a.m. Oct. 14, 2021

    - Barron's Online

  11. Merck Submits Covid Pill to FDA for Emergency Approval

    10:11 a.m. Oct. 11, 2021

    - Barron's Online

  12. Dice Therapeutics and Hemisphere Media See Activist Action

    9:30 p.m. Oct. 1, 2021

    - Barron's Online

  13. Merck Says Pill Cuts Covid Hospitalization by 50%

    4:41 p.m. Oct. 1, 2021

    - Barron's Online

  14. Merck: Covid-19 Pill Looks Good Against Variants

    4:36 p.m. Sept. 29, 2021

    - Barron's Online

  15. Loading more headlines...
/news/nonmarketwatch/company/us/avir

Other News on AVIR

  1. Atea (AVIR) Dengue Candidate Gets Fast Track Designation

    9:53 a.m. Today

    - Zacks.com

  2. Atea wins FDA Fast Track status for dengue treatment

    7:44 a.m. Sept. 26, 2022

    - Seeking Alpha

  3. AJU IB Investment Co., Ltd. Buys 3, Sells 2 in 2nd Quarter

    9:00 a.m. Aug. 9, 2022

    - GuruFocus.com

  4. 10-Q: ATEA PHARMACEUTICALS, INC.

    4:46 p.m. Aug. 8, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  5. Notable earnings after Monday's close

    5:35 p.m. Aug. 7, 2022

    - Seeking Alpha

  6. 10-Q: ATEA PHARMACEUTICALS, INC.

    8:04 a.m. May 10, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  7. Notable earnings after Monday's close

    5:35 p.m. May 8, 2022

    - Seeking Alpha

  8. Biotech Stocks, Once Booming, Enter Bear Territory

    2:32 a.m. April 4, 2022

    - The Wall Street Journal Interactive Edition

  9. RIOT, MARA and HIVE among pre market gainers

    9:46 a.m. March 1, 2022

    - Seeking Alpha

  10. Loading more headlines...
/news/pressrelease/company/us/avir

Press Releases on AVIR

  1. Atea Pharmaceuticals Announces Upcoming Investor Events

    7:00 a.m. Sept. 7, 2022

    - GlobeNewswire

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.